Kelyniam Custom Skull Implant (CSI)
Medical device recall Z-1873-2018. Published in FDA’s Enforcement Report on May 23, 2018.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on May 23, 2018. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word for where it went
- 54 how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
Significant design changes made to the Custom Skull Implant (CSI) devices, such as removing pressure relief holes across the length of the device and adding suture holes along the ridge of the implant, were not validated or submitted to FDA for marketing clearance. The Temporal Suture System (TSS) is no longer being offered and the Integrated Fixation System (IFS) has been temporarily suspended
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
Kelyniam Custom Skull Implant (CSI), Model no. PEEK-IM1004
54, in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
Marketing Material: All revisions up to rev. A. IFU: All revisions up to rev. C. Case Numbers: CSI070314-JF1 CSI082214-EC1 CSI090314-CG1 CSI091614-JB1 CSI101414-RA1 CSI110514-SS2 CSI120814-JC1 CSI121114-DD1 CSI121614-LG1 CSI121714-OL1…
Every code shown here, 853 characters
Marketing Material: All revisions up to rev. A. IFU: All revisions up to rev. C. Case Numbers: CSI070314-JF1 CSI082214-EC1 CSI090314-CG1 CSI091614-JB1 CSI101414-RA1 CSI110514-SS2 CSI120814-JC1 CSI121114-DD1 CSI121614-LG1 CSI121714-OL1 CSI011615-AC1 CSI012915-JG1 CSI012915-SS1 CSI022415-HL1 CSI040615-RA1 CSI060115-EB1 CSI102215-CT1 CSI112415-ES1 CSI101615-BE1 CSI012016-RT1B CSI022916-CS1 CSI032216-SP1 CSI020216-JR1 CSI051716-TM1 CSI070516-AT1 CSI070116-EG1 CSI072816-JE1 CSI092716-AV1 CSI101416-TY1 CSI110816-CS1 CSI112316-NK1 CSI092616-CB1 CSI111516-RB1 CSI113016-NR1 CSI111616-FH1 CSI010517-JH1 CSI041417-KK1 CSI060117-AR1 CSI062617-LV1 CSI071017-NS1A CSI081717-GG1 CSI081717-JM1 CSI082717-LH1 CSI082917-UK1 CSI081717-JM1 CSI090617-JH2 CSI092717-DH1 CSI092617-OT1 CSI100417-EZ1 CSI100517-AE1 CSI100617-MH1 CSI101817-KD1 CSI102617-NK1 CSI101617-JF1B
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
US nationwide distribution.
These words name no state.
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Jun 10, 2017.
- FDA classified it on May 14, 2018.
- FDA’s Enforcement Report published it on May 23, 2018.
- FDA terminated it on Sep 14, 2020.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- Kelyniam Global, Inc., of Collinsville, CT.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.